Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Allogeneic Cells (Phase 1)
Allografts (Phase 1)
Amyotrophic Lateral Sclerosis (Phase 1/Phase 2)
Anterior Wall Myocardial Infarction (Phase 3)
Cardiomyopathies (Phase 2)
Cardiovascular Diseases (Phase 1/Phase 2)
Coronary Artery Disease (Phase 2)
COVID-19 (Phase 2)
Diabetes Mellitus, Type 1 (Phase 1/Phase 2)
Diabetes Mellitus, Type 2 (Phase 1/Phase 2)
Diabetic Nephropathies (Phase 1/Phase 2)
Erectile Dysfunction (Phase 1/Phase 2)
Fractures, Bone (Phase 2)
Graft vs Host Disease (Phase 1)
Heart Failure (Phase 3)
Inflammatory Bowel Diseases (Phase 1/Phase 2)
Influenza A virus (Phase 1)
Knee Injuries (Phase 2)
Mesenchymal Stem Cell Transplantation (Phase 1/Phase 2)
Metapneumovirus (Phase 1)
Myocardial Infarction (Phase 3)
Osteoarthritis (Phase 1/Phase 2)
Osteoarthritis, Hip (Phase 1/Phase 2)
Osteoarthritis, Knee (Phase 2)
Osteoporotic Fractures (Phase 2)
Poisoning (Phase 3)
Regenerative Medicine (Phase 3)
Respiratory Distress Syndrome (Phase 1/Phase 2)
Respiratory Syncytial Virus Infections (Phase 1)
Retinal Diseases (Phase 3)
Retinitis Pigmentosa (Phase 3)
SARS-CoV-2 (Phase 1/Phase 2)
Spinal Cord Injuries (Phase 1/Phase 2)
ST Elevation Myocardial Infarction (Phase 3)
Stem Cells (Phase 3)
Toxic Optic Neuropathy (Phase 3)
Transcranial Magnetic Stimulation (Phase 3)
Ventricular Remodeling (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue